StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

LeMaitre Vascular's ebitda for the twelve months ending Jun 30, 2026 was $87.82M, up 35.5% year over year. For fiscal 2025 it was $78.33M, up 26.6% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $78.33M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.33M+26.6%
FY2024Dec 31, 2024$61.86M+33.8%
FY2023Dec 31, 2023$46.23M+27.5%
FY2022Dec 31, 2022$36.26M-23.7%
FY2021Dec 31, 2021$47.50M+27.7%
FY2020Dec 31, 2020$37.18M+39.8%
FY2019Dec 31, 2019$26.60M-18.2%
FY2018Dec 31, 2018$32.53M+29.3%
FY2017Dec 31, 2017$25.16M+26.3%
FY2016Dec 31, 2016$19.93M+33.7%
FY2015Dec 31, 2015$14.91M+54.1%
FY2014Dec 31, 2014$9.67M+32.3%
FY2013Dec 31, 2013$7.31M+12.9%
FY2012Dec 31, 2012$6.47M+13.0%
FY2011Dec 31, 2011$5.73M+6.2%
FY2010Dec 31, 2010$5.39M+60.1%
FY2009Dec 31, 2009$3.37M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.06M+22.7%
Q1 FY2026Mar 31, 2026$20.40M+34.4%
Q4 FY2025Dec 31, 2025$21.44M+40.4%
Q3 FY2025Sep 30, 2025$22.93M+47.2%
Q2 FY2025Jun 30, 2025$18.79M+12.1%
Q1 FY2025Mar 31, 2025$15.18M+6.5%
Q4 FY2024Dec 31, 2024$15.27M+20.7%
Q3 FY2024Sep 30, 2024$15.57M+34.5%
Q2 FY2024Jun 30, 2024$16.76M+42.3%
Q1 FY2024Mar 31, 2024$14.26M+39.4%
Q4 FY2023Dec 31, 2023$12.65M+36.7%
Q3 FY2023Sep 30, 2023$11.58M+36.5%
Q2 FY2023Jun 30, 2023$11.78M+43.1%
Q1 FY2023Mar 31, 2023$10.23M-0.7%
Q4 FY2022Dec 31, 2022$9.26M-17.3%
Q3 FY2022Sep 30, 2022$8.48M-29.3%
Q2 FY2022Jun 30, 2022$8.23M-40.1%
Q1 FY2022Mar 31, 2022$10.30M-2.5%
Q4 FY2021Dec 31, 2021$11.19M-7.4%
Q3 FY2021Sep 30, 2021$12.00M-5.5%
Q2 FY2021Jun 30, 2021$13.74M+111.1%
Q1 FY2021Mar 31, 2021$10.57M+79.4%
Q4 FY2020Dec 31, 2020$12.08M+89.7%
Q3 FY2020Sep 30, 2020$12.70M+75.2%
Q2 FY2020Jun 30, 2020$6.51M-10.3%
Q1 FY2020Mar 31, 2020$5.89M+3.0%
Q4 FY2019Dec 31, 2019$6.37M-24.3%
Q3 FY2019Sep 30, 2019$7.25M+29.0%
Q2 FY2019Jun 30, 2019$7.26M-42.4%
Q1 FY2019Mar 31, 2019$5.72M-3.0%
Q4 FY2018Dec 31, 2018$8.41M+13.5%
Q3 FY2018Sep 30, 2018$5.62M-7.2%
Q2 FY2018Jun 30, 2018$12.61M+93.4%
Q1 FY2018Mar 31, 2018$5.90M+14.0%
Q4 FY2017Dec 31, 2017$7.41M+53.0%
Q3 FY2017Sep 30, 2017$6.06M-2.1%
Q2 FY2017Jun 30, 2017$6.52M–
Q1 FY2017Mar 31, 2017$5.17M–
Q4 FY2016Dec 31, 2016$4.84M–
Q3 FY2016Sep 30, 2016$6.19M–

More LeMaitre Vascular figures

See a number that looks wrong?